Shin Yonehara

Kyoto University

Papers

1

Total Citations

50

H-Index

1

About

Shin Yonehara is a pioneer in the emerging field of protein-driven RNA nanotechnology, where he designs dynamic nanostructures that respond to biological signals. His most cited work, a 2017 study in *Nature Communications* (50 citations), introduced the first RNA-based devices capable of detecting specific protein inputs and, in turn, controlling mammalian cell fate. This breakthrough overcomes a major hurdle in therapeutic nanotech: creating structures that are not only programmable but also responsive to native cellular cues. By engineering RNA to function as both a sensor and an actuator, Yonehara’s research bridges synthetic biology and nanomedicine, opening new avenues for smart drug delivery and regenerative therapies. His contributions are foundational for the development of “living” nanodevices that can diagnose disease states and trigger precise therapeutic responses directly inside cells. With a growing citation footprint, Yonehara is recognized for pushing the boundaries of what nucleic acid nanostructures can achieve in complex biological environments, making him a key figure to watch in the next generation of molecular engineering.

Research Focus

Key Achievements

1
H-Index
1
Papers
50
Total Citations
50
Avg Citations/Paper
🏆 Most Cited Paper
Protein-driven RNA nanostructured devices that function in vitro and control mammalian cell fate
50 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Kyoto University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago